Rebif injections are given three times per week for multiple sclerosis (MS) and clinically isolated syndrome (CIS). You’ll start with a low dose of Rebif for the first 4 weeks of treatment. Your ...
- New Formulation of Rebif(R) Designed to Improve Injection Tolerability Merck Serono, a division of Merck KGaA, announced today that the European Commission has ...
The FDA has approved Rebif Rebidose, a single-use auto-injector prefilled with EMD Serono and Pfizer's ($PFE) interferon beta-1a, for the treatment of relapsing forms ...
Serono SA released impressive 24-week data from its 677-patient, head-to-head study of its product Rebif vs. Biogen Inc. s Avonex in patients with relapsing-remitting multiple sclerosis, and is ...
Rebif (interferon beta-1a) is a prescription drug used to treat some types of multiple sclerosis (MS). Rebif may be safe to use while pregnant or breastfeeding. Keep ...
DARMSTADT, Germany, October 18, 2017/PRNewswire/. Merck, a leading science and technology company, today announced that data for approved and investigational multiple sclerosis (MS) treatments, ...
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that new pregnancy outcomes data in women with MS treated with interferon beta (IFN β), including ...
What Biogen says is that it plans to hang onto its lead in the U.S., and James Mullen, Biogen’s president and CEO, responded to the Rebif approval with a press release of Biogen’s own. Mullen called ...
Merck, a leading science and technology company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion to update ...
March 16, 2005 — The U.S. Food and Drug Administration (FDA) approved in December 2004 revisions to safety labeling to advise healthcare professionals of the following changes: use of interferon ...
On September 20, the European Commission approved 30- and 45-mg strengths of oseltamivir phosphate capsules (Tamiflu, Hoffmann-La Roche Ltd) for the treatment and prevention of influenza types A and B ...